Computing Publications

Publications Home » Multi-region analysis of longitud...

Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease

Katherine Gray, Robin Wolz, R. A. Heckemann, Paul Aljabar, A. Hammers, Daniel Rueckert, The Alzheimer's Disease Neuroimaging Initiative (ADNI)

Journal Article
NeuroImage
Volume 60
Issue 1
pp.221–229
March, 2012
Elsevier
DOI 10.1016/j.neuroimage.2011.12.071
Abstract

Imaging biomarkers for Alzheimer's disease are desirable for improved diagnosis and monitoring, as well as drug discovery. Automated image-based classification of individual patients could provide valuable diagnostic support for clinicians, when considered alongside cognitive assessment scores. We investigate the value of combining cross-sectional and longitudinal multi-region FDG-PET information for classification, using clinical and imaging data from the Alzheimer's Disease Neuroimaging Initiative. Whole-brain segmentations into 83 anatomically defined regions were automatically generated for baseline and 12-month FDG-PET images. Regional signal intensities were extracted at each timepoint, as well as changes in signal intensity over the follow-up period. Features were provided to a support vector machine classifier. By combining 12-month signal intensities and changes over 12 months, we achieve significantly increased classification performance compared with using any of the three feature sets independently. Based on this combined feature set, we report classification accuracies of 88% between patients with Alzheimer's disease and elderly healthy controls, and 65% between patients with stable mild cognitive impairment and those who subsequently progressed to Alzheimer's disease. We demonstrate that information extracted from serial FDG-PET through regional analysis can be used to achieve state-of-the-art classification of diagnostic groups in a realistic multi-centre setting. This finding may be usefully applied in the diagnosis of Alzheimer's disease, predicting disease course in individuals with mild cognitive impairment, and in the selection of participants for clinical trials.

BibTEX file for the publication
 

pubs.doc.ic.ac.uk: built & maintained by Ashok Argent-Katwala.